Welcome to our dedicated page for Evolent Health news (Ticker: EVH), a resource for investors and traders seeking the latest updates and insights on Evolent Health stock.
Evolent Health, Inc. (NYSE: EVH) plays a pivotal role in the healthcare sector by supporting health systems and physician organizations in their transition to value-based care and population health management. Headquartered in Arlington, Virginia, Evolent is backed by major entities such as The Advisory Board Company, University of Pittsburgh Medical Center Health Plan, and TPG Growth. The company’s core business revolves around providing integrated specialty care management services, total cost of care management, and health plan administration through an all-inclusive platform.
Evolent specializes in managing complex conditions in fields such as oncology, cardiology, and musculoskeletal markets, aiming to simplify healthcare and make it more affordable. The company's recent achievements include exceeding profitability expectations in the third quarter of 2023, adding new operating partnerships, and enhancing its financial outlook for the year. Evolent reported robust financial health with $184.5 million in cash and cash equivalents as of September 30, 2023.
The company’s culture is centered around collaboration, innovation, and a supportive work environment. Benefits like treadmill desks, healthy snacks, and wellness challenges underscore its commitment to employee well-being.
Notably, Evolent is also venturing into AI-driven healthcare solutions, as evidenced by its recent agreement to acquire Machinify Auth, a software platform that enhances clinical quality through advanced AI. This acquisition is expected to significantly improve the speed and efficiency of clinical reviews for various conditions.
In summary, Evolent Health continues to be a significant player in the healthcare industry, driving better health outcomes and financial performance through innovative solutions.
Evolent Health (NYSE: EVH) announced a partnership with PCG Consulting Group to establish a customer contact team in Cook County, Illinois, serving over 400,000 Medicaid members. This collaboration aims to enhance diversity and support minority communities. PCG, with 79% of its employees from underserved areas, provides crucial administrative and clinical services. The initiative aligns with Evolent's commitment to health equity and improving member experiences, particularly for Black and African American individuals in the area. The partnership is part of Evolent's broader strategy to promote diversity and community engagement.
Evolent Health (NYSE: EVH) will present at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 4:30 p.m. ET. CEO Seth Blackley and CFO John Johnson will participate in the virtual event. Investors can access a live audio-only webcast on Evolent's website, with a replay available shortly after the event. Evolent Health provides clinical and administrative solutions aimed at improving health care affordability and efficiency, and it serves a nationwide base of healthcare payers and providers.
Evolent Health, Inc. (NYSE: EVH) has appointed Seth R. Frank as the new Vice President of Investor Relations, effective immediately. Reporting to CFO John Johnson, Frank will enhance the company's investor relations strategy and engagement with the investment community. He brings extensive experience from roles at Hanger, Inc. and Allscripts, along with a background as an equity analyst. This strategic appointment aims to boost investor knowledge of Evolent's operations and reinforce its commitment to delivering long-term shareholder value.
Evolent Health, Inc. (NYSE: EVH) announced that CFO John Johnson will lead a panel titled "Evolent Health Spotlight: New Century Health - Oncology Care Reimagined" on November 18, 2021, from 12-1 pm ET. The panel will include physicians from New Century Health, a subsidiary of Evolent, and partners discussing advancements in oncology care. Interested participants can register and access the event's live webcast via the company's website. The session will last approximately 60 minutes, including a Q&A segment. A replay will be available on the investor relations page afterward.
Evolent Health (NYSE: EVH) announced that CEO Seth Blackley and CFO John Johnson will attend the Piper Sandler 33rd Annual Healthcare Conference on December 1, 2021. The company specializes in clinical and administrative solutions aimed at enhancing health care quality while reducing costs. Evolent is recognized for its innovative contributions to population health management and has received national accolades for its workplace environment. For more information, visit evolenthealth.com.
Evolent Health (NYSE: EVH) announced a partnership with Health New England to provide advanced care planning services via its subsidiary, New Century Health. The initiative, utilizing the Vital Decisions platform, aims to support Health New England's 180,000 members in articulating their healthcare preferences during serious illness. Through personalized consultations, the Living Well program allows patients to document their care goals, ensuring that their choices are reflected in medical plans. This partnership seeks to empower patients and enhance their healthcare experience.
Evolent Health (NYSE: EVH) announces the appointment of Dr. Tunde Sotunde to its Board of Directors, bringing over 20 years of healthcare experience. Dr. Sotunde, currently CEO of Blue Cross and Blue Shield of North Carolina, replaces Michael D'Amato, who is retiring. His leadership at Anthem, where he oversaw Medicaid efforts serving 7.3 million members and generating $33 billion in revenue, underscores his expertise. Additionally, effective January 1, 2022, Frank Williams transitions from Executive Chairman to non-executive Chairman, reflecting the company's governance evolution.
Evolent Health, Inc. (NYSE: EVH) reported third-quarter 2021 financial results, revealing GAAP revenue of $222.5 million, a 7.1% decrease from the previous year. Excluding divested assets, revenue grew 36.3%. The net loss for common shareholders was $(13.0) million, with an adjusted EBITDA of $13.8 million. Total lives managed reached 14.7 million. The company announced new partnerships, exceeding its target of ten for 2021. Full year revenue guidance is revised to $884-$900 million, with adjusted EBITDA expected between $56-$60 million.
Evolent Health (NYSE: EVH) will announce its third quarter 2021 operating results on November 3, 2021, after market close. A conference call is scheduled for 5:30 p.m. Eastern Time the same day. Interested participants can join by calling 855.940.9467 or 412.317.6034 for international listeners, mentioning the "Evolent Health call" 15 minutes prior. The call will also be available for playback on Evolent's investor relations website for a week post-call. Evolent Health specializes in health care solutions aimed at improving affordability and simplifying care delivery.
On October 6, 2021, WindRose Health Investors announced the sale of Vital Decisions, a provider of technology-enabled advance care-planning services, to Evolent Health (NYSE: EVH). This acquisition positions Vital Decisions under Evolent's specialty management division, New Century Health, thus integrating into Evolent’s Clinical Solutions segment. Vital Decisions aims to ensure individuals' healthcare aligns with their values using advanced methodologies and analytics. WindRose had partnered with Vital Decisions since 2012, resulting in significant growth.
FAQ
What is the current stock price of Evolent Health (EVH)?
What is the market cap of Evolent Health (EVH)?
What is the primary business of Evolent Health, Inc.?
Where is Evolent Health headquartered?
What recent financial achievements has Evolent Health reported?
What are some of the core services provided by Evolent Health?
What recent acquisition did Evolent Health announce?
Who are some of the backers of Evolent Health?
What are the primary specialty care areas Evolent focuses on?
How does Evolent Health view its company culture?
What is the significance of Evolent’s acquisition of Machinify Auth?
How has Evolent Health performed financially in recent quarters?
